Business · 07/11/2011
FDA Releases Guidance for Industry on Clinical Considerations for Therapeutic Cancer Vaccines
The FDA has made available a document providing recommendations for sponsors seeking to develop and market therapeutic cancer vaccines, outlining critical clinical considerations for investigational studies and clinical trial design to support a biologics license application.
Original source language: Federal Register — Health and Human ServicesOpen original release →